Gen-Probe, Affy Provide Updates at Conference | GenomeWeb

NEW YORK (GenomeWeb News) – Gen-Probe and Affymetrix presented updates on their businesses for investors at the Thomas Weisel Healthcare Conference being held this week in Boston.

Gen-Probe officials said that the firm is on track with clinical trials for its Aptima HPV assay and expects to file for US Food and Drug Administration clearance of the test by the end of 2010. They also said that Panther, Gen-Probe's fully automated molecular instrument, is on schedule for a late 2010 launch in Europe, followed by a US launch in 2011.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.

In Science this week: new chromatin imaging approach, and more.